- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
NIH Unleashes Mondo-Mega-Grants to Devour Disease
14 April 2009 3:02 pm
Scientists are racing to get their applications in for NIH's latest scheme for using the $10.4 billion it got in the stimulus bill—jumbo-sized Grand Opportunities, or GO, grants. It will spend $200 million on 2-year awards funded for $1 million or more—at least 35% larger than R01 grants, the mainstay of the NIH system.
Unlike NIH's other big stimulus competition, the Challenge Grants, which can be up to $1 million, the GO projects will require at least that much money. NIH wants to fund "high impact" short-term projects, which could mean answering a research question or creating infrastructure. That might entail validating disease biomarkers or using information technology to share radiology images across hospitals.
Many NIH institutes have listed specific projects they're interested in.
Johns Hopkins University molecular pathologist Anirban Maitra says the GO grants are "like a big sister" to the Challenge Grants; he suggests that only "the big guys" will try for them. Unlike the Challenge Grants, which could draw 10,000 applications, this competition won't generate an avalanche of proposals that have to be peer-reviewed. That's because grant seekers first have to send NIH a letter of intent (by 27 April), which NIH staff will use to pare down the possible proposals. The agency announced the GO competition on 23 March but for some reason only got around to issuing a press release today.